Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07851259 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Efficacy and Safety of RO7965032 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

StatusNot Yet Recruiting
PhasePhase 2
Started2026-09-30
View on ClinicalTrials.gov ↗
364 trials monitored
See 34 trials at risk
This study will assess the safety and efficacy of RO7965032 to address a significant unmet medical need in participants with geographic atrophy (GA) secondary to age-related macular degeneration (AMD)
Trial Details
NCT Number NCT07851259
Lead Sponsor Genentech, Inc.
Conditions Geographic Atrophy Secondary to Age-Related Macular Degeneration
Enrollment 321 participants
Start Date 2026-09-30
Primary Completion 2030-08-21 (estimated)
Study Completion 2030-08-21 (estimated)
Updated on ClinicalTrials.gov 2026-10-01